Dry eye disease management
BMJ
.
2024 Mar 25:384:e077344.
doi: 10.1136/bmj-2023-077344.
Authors
Margarita Safir
1
2
,
Gilad Twig
3
4
,
Michael Mimouni
5
Affiliations
1
Ophthalmology Department, Yitzhak Shamir Medical Center, Zerifin, Israel.
2
Faculty of Medicine, Tel Aviv University, Israel.
3
Department of Epidemiology and Preventive Medicine, School of Public Health, Tel Aviv University, Israel.
4
The Gertner Institute for Epidemiology & Health Policy Research, Sheba Medical Center, Ramat Gan, Israel.
5
Ophthalmology Department, Rambam Health Care Campus, Haifa, Israel.
PMID:
38527751
DOI:
10.1136/bmj-2023-077344
No abstract available
MeSH terms
Disease Management
Dry Eye Syndromes* / etiology
Dry Eye Syndromes* / therapy
Humans
Ophthalmic Solutions / therapeutic use
Substances
Ophthalmic Solutions